Zhou H - Search Results

1

Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia.

Xie C, Edwards H, Xu X, Zhou H, Buck SA, Stout ML, Yu Q, Rubnitz JE, Matherly LH, Taub JW, Ge Y. Xie C, et al. Among authors: zhou h. Clin Cancer Res. 2010 Nov 15;16(22):5499-510. doi: 10.1158/1078-0432.CCR-10-1707. Epub 2010 Oct 1. Clin Cancer Res. 2010. PMID: 20889917 Free PMC article.

2

Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells.

Xu X, Xie C, Edwards H, Zhou H, Buck SA, Ge Y. Xu X, et al. Among authors: zhou h. PLoS One. 2011 Feb 16;6(2):e17138. doi: 10.1371/journal.pone.0017138. PLoS One. 2011. PMID: 21359182 Free PMC article.

3

Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia.

Zhou H, Qin D, Xie C, Zhou J, Jia S, Zhou Z, Qiu Y, Xu B, Zha J. Zhou H, et al. Among authors: zhou j, zhou z. Clin Cancer Res. 2024 Dec 2;30(23):5430-5444. doi: 10.1158/1078-0432.CCR-24-0796. Clin Cancer Res. 2024. PMID: 39321217

4

Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia.

Zhou H, Jiang Y, Huang Y, Zhong M, Qin D, Xie C, Pan G, Tan J, Deng M, Zhao H, Zhou Y, Tang Y, Lai Q, Fang Z, Luo Y, Jiang Y, Xu B, Zha J. Zhou H, et al. Among authors: zhou y. Cancer Lett. 2023 Feb 1;554:215997. doi: 10.1016/j.canlet.2022.215997. Epub 2022 Nov 15. Cancer Lett. 2023. PMID: 36396101

5

Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia.

Xie C, Zhou H, Qin D, Zheng H, Tang Y, Li W, Zhou J, Liu L, Yu X, Duan H, Zhou Y, Li Z, Fang Z, Luo Y, Carter BZ, Xu B, Zha J. Xie C, et al. Among authors: zhou h, zhou y, zhou j. Cell Death Dis. 2023 Aug 29;14(8):573. doi: 10.1038/s41419-023-06075-6. Cell Death Dis. 2023. PMID: 37644011 Free PMC article.

6

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.

Zhao A, Zhou H, Yang J, Li M, Niu T. Zhao A, et al. Among authors: zhou h. Signal Transduct Target Ther. 2023 Feb 17;8(1):71. doi: 10.1038/s41392-023-01342-6. Signal Transduct Target Ther. 2023. PMID: 36797244 Free PMC article. Review.

7

Stratification and therapeutic potential of ELL in cytogenetic normal acute myeloid leukemia.

Zha J, Zhong M, Pan G, Chen Q, Jiang Y, Lai Q, Tan J, Zhou H, Wu H, Xu B. Zha J, et al. Among authors: zhou h. Gene. 2023 Mar 10;856:147110. doi: 10.1016/j.gene.2022.147110. Epub 2022 Dec 18. Gene. 2023. PMID: 36543308 Free article.

8

Role of immune cell homeostasis in research and treatment response in hepatocellular carcinoma.

Song W, Li M, Liu W, Xu W, Zhou H, Wei S, Chi J. Song W, et al. Among authors: zhou h. Clin Exp Med. 2025 Jan 18;25(1):42. doi: 10.1007/s10238-024-01543-5. Clin Exp Med. 2025. PMID: 39826024

9

Real-Time Auto Controlling of Viable Cell Density in Perfusion Cultivation Aided by In-Line Dielectric Spectroscopy With Segmented Adaptive PLS Model.

Sun Y, Zhang Q, He Y, Chen D, Wang Z, Zheng X, Fang M, Zhou H. Sun Y, et al. Among authors: zhou h. Biotechnol Bioeng. 2025 Jan 17. doi: 10.1002/bit.28930. Online ahead of print. Biotechnol Bioeng. 2025. PMID: 39825569

10

Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation.

Huang T, Wei L, Zhou H, Liu J. Huang T, et al. Among authors: zhou h. Cancer Med. 2025 Jan;14(2):e70604. doi: 10.1002/cam4.70604. Cancer Med. 2025. PMID: 39825491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,813 results

Search Page

Filters